Among the 128 new 52-week lows on the NYSE on Tuesday, there were five with share prices of $100 or higher. Not all of them ...
OpenAI is moving away from side quests as it prepares the business and financials for an IPO.
Eli Lilly stock rallies as the firm’s oral weight-loss pill, Foundayo, secures FDA approval. Options pricing suggests LLY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results